260 related articles for article (PubMed ID: 32721115)
1. Potential role of cancer stem cells as biomarkers and therapeutic targets in cervical cancer.
Sudhalkar N; Rathod NP; Mathews A; Chopra S; Sriram H; Shrivastava SK; Goda JS
Cancer Rep (Hoboken); 2019 Apr; 2(2):e1144. PubMed ID: 32721115
[TBL] [Abstract][Full Text] [Related]
2. Cancer stem cells (CSCs), cervical CSCs and targeted therapies.
Huang R; Rofstad EK
Oncotarget; 2017 May; 8(21):35351-35367. PubMed ID: 27343550
[TBL] [Abstract][Full Text] [Related]
3. Cancer Stem Cells-Origins and Biomarkers: Perspectives for Targeted Personalized Therapies.
Walcher L; Kistenmacher AK; Suo H; Kitte R; Dluczek S; Strauß A; Blaudszun AR; Yevsa T; Fricke S; Kossatz-Boehlert U
Front Immunol; 2020; 11():1280. PubMed ID: 32849491
[TBL] [Abstract][Full Text] [Related]
4. Cervical cancer stem cells: opportunities and challenges.
Chhabra R
J Cancer Res Clin Oncol; 2015 Nov; 141(11):1889-97. PubMed ID: 25563493
[TBL] [Abstract][Full Text] [Related]
5. Cervical cancer stem cells.
Yao T; Lu R; Zhang Y; Zhang Y; Zhao C; Lin R; Lin Z
Cell Prolif; 2015 Dec; 48(6):611-25. PubMed ID: 26597379
[TBL] [Abstract][Full Text] [Related]
6. Cervical cancer cells with positive Sox2 expression exhibit the properties of cancer stem cells.
Liu XF; Yang WT; Xu R; Liu JT; Zheng PS
PLoS One; 2014; 9(1):e87092. PubMed ID: 24489842
[TBL] [Abstract][Full Text] [Related]
7. Cancer Stem Cells and Their Possible Implications in Cervical Cancer: A Short Review.
Di Fiore R; Suleiman S; Drago-Ferrante R; Subbannayya Y; Pentimalli F; Giordano A; Calleja-Agius J
Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563557
[TBL] [Abstract][Full Text] [Related]
8. Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target.
Yan Y; Zuo X; Wei D
Stem Cells Transl Med; 2015 Sep; 4(9):1033-43. PubMed ID: 26136504
[TBL] [Abstract][Full Text] [Related]
9. The Prognostic Value of Cancer Stem Cell Markers in Cervical Cancer: A Systematic Review and Meta-Analysis.
Fahmi MN; Hertapanndika IN; Kusuma F
Asian Pac J Cancer Prev; 2021 Dec; 22(12):4057-4065. PubMed ID: 34967589
[TBL] [Abstract][Full Text] [Related]
10. Enrichment and characterization of cancer stem‑like cells from a cervical cancer cell line.
Wang L; Guo H; Lin C; Yang L; Wang X
Mol Med Rep; 2014 Jun; 9(6):2117-23. PubMed ID: 24676900
[TBL] [Abstract][Full Text] [Related]
11. Low P16
Fu HC; Chuang IC; Yang YC; Chuang PC; Lin H; Ou YC; Chang Chien CC; Huang HS; Kang HY
Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30150594
[TBL] [Abstract][Full Text] [Related]
12. Molecular iodine inhibits the expression of stemness markers on cancer stem-like cells of established cell lines derived from cervical cancer.
Bigoni-Ordóñez GD; Ortiz-Sánchez E; Rosendo-Chalma P; Valencia-González HA; Aceves C; García-Carrancá A
BMC Cancer; 2018 Sep; 18(1):928. PubMed ID: 30257666
[TBL] [Abstract][Full Text] [Related]
13. Photodynamic therapy with 5-aminolevulinic acid (ALA) impairs tumor initiating and chemo-resistance property in head and neck cancer-derived cancer stem cells.
Yu CH; Yu CC
PLoS One; 2014; 9(1):e87129. PubMed ID: 24475244
[TBL] [Abstract][Full Text] [Related]
14. Identification and characterization of cancer stem-like cells from primary carcinoma of the cervix uteri.
Feng D; Peng C; Li C; Zhou Y; Li M; Ling B; Wei H; Tian Z
Oncol Rep; 2009 Nov; 22(5):1129-34. PubMed ID: 19787230
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of Gremlin 1 in cervical cancer and its effects on cancer stem cell maintenance.
Sato M; Kawana K; Fujimoto A; Yoshida M; Nakamura H; Nishida H; Inoue T; Taguchi A; Takahashi J; Adachi K; Nagasaka K; Matsumoto Y; Wada-Hiraike O; Oda K; Osuga Y; Fujii T
Oncol Rep; 2016 Jan; 35(1):391-7. PubMed ID: 26530461
[TBL] [Abstract][Full Text] [Related]
16. BRM270 Suppresses Cervical Cancer Stem Cell Characteristics and Progression by Inhibiting SOX2.
Chandimali N; Sun HN; Park YH; Kwon T
In Vivo; 2020; 34(3):1085-1094. PubMed ID: 32354896
[TBL] [Abstract][Full Text] [Related]
17. Co-expressed functional module-related genes in ovarian cancer stem cells represent novel prognostic biomarkers in ovarian cancer.
Gov E
Syst Biol Reprod Med; 2020 Aug; 66(4):255-266. PubMed ID: 32441533
[TBL] [Abstract][Full Text] [Related]
18. Unraveling the roles of CD44/CD24 and ALDH1 as cancer stem cell markers in tumorigenesis and metastasis.
Li W; Ma H; Zhang J; Zhu L; Wang C; Yang Y
Sci Rep; 2017 Oct; 7(1):13856. PubMed ID: 29062075
[TBL] [Abstract][Full Text] [Related]
19. Zoledronic acid inhibits the growth of cancer stem cell derived from cervical cancer cell by attenuating their stemness phenotype and inducing apoptosis and cell cycle arrest through the Erk1/2 and Akt pathways.
Wang L; Liu Y; Zhou Y; Wang J; Tu L; Sun Z; Wang X; Luo F
J Exp Clin Cancer Res; 2019 Feb; 38(1):93. PubMed ID: 30791957
[TBL] [Abstract][Full Text] [Related]
20. α-Mangostin attenuates stemness and enhances cisplatin-induced cell death in cervical cancer stem-like cells through induction of mitochondrial-mediated apoptosis.
Chien HJ; Ying TH; Hsieh SC; Lin CL; Yu YL; Kao SH; Hsieh YH
J Cell Physiol; 2020 Jul; 235(7-8):5590-5601. PubMed ID: 31960449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
